|
1
|
Ng E, Choong AM and Walker PJ: Neovascular
glaucoma post carotid endarterectomy: A case report and review of
the literature. Ann Vasc Dis. 8:103–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kiddee W, Tantisarasart T and
Wangsupadilok B: Neovascular glaucoma: A retrospective review of
5-year experience in Songklanagarind Hospital. J Med Assoc Thai. 95
Suppl 4:S36–S42. 2012.PubMed/NCBI
|
|
3
|
Martinez-Carpio PA, Bonafonte-Márquez E,
Heredia-Garcia CD and Bonafonte-Royo S: Efficacy and safety of
intravitreal injection of bevacizumab in the treatment of
neovascular glaucoma: Systematic review. Arch Soc Esp Oftalmol.
83:579–588. 2008.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takihara Y, Inatani M, Fukushima M, Iwao
K, Iwao M and Tanihara H: Trabeculectomy with mitomycin C for
neovascular glaucoma: Prognostic factors for surgical failure. Am J
Ophthalmol. 147(912–918): e12009.
|
|
5
|
Mishra KK, Daftari IK, Weinberg V, Cole T,
Quivey JM, Castro JR, Phillips TL and Char DH: Risk factors for
neovascular glaucoma after proton beam therapy of uveal melanoma: A
detailed analysis of tumor and dose-volume parameters. Int J Radiat
Oncol Biol Phys. 87:330–336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goto A, Inatani M, Inoue T, Awai-Kasaoka
N, Takihara Y, Ito Y, Fukushima M and Tanihara H: Frequency and
risk factors for neovascular glaucoma after vitrectomy in eyes with
proliferative diabetic retinopathy. J Glaucoma. 22:572–576. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calugaru D and Calugaru M: Neovascular
glaucoma-etipathogeny and diagnosis. Oftalmologia. 56:3–14.
2012.(In Romanian). PubMed/NCBI
|
|
8
|
Rachitskaya AV, Lee RK, Dubovy SR and
Schiff ER: Combined central retinal vein and central retinal artery
occlusions and neovascular glaucoma associated with interferon
treatment. Eur J Ophthalmol. 22:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Altintas AG, Arifoglu HB, Tutar E, Koklu G
and Ozcan PY: Effect on anterior chamber bevacizumab injection
combined with seton implantation in treatment of rubeosis iridis in
neovascular glaucoma. Cutan Ocul Toxicol. 31:124–127. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Caujolle JP, Maschi C, Freton A, Pages G
and Gastaud P: Treatment of neovascular glaucoma after proton
therapy for uveal melanomas with ranibizumab injection: Preliminary
results. Ophthalmic Res. 47:57–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Călugăru D and Călugăru M: Treatment of
neovascular glaucoma. Oftalmologia. 56:20–39. 2012.(In
Romanian).
|
|
12
|
Zhou WY and Li YH: A survey on treatment
of dry eye by traditional chinese medicine and integrative chinese
and Western medicine. Chin J Integr Med. 12:154–159. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mi XS, Zhong JX, Chang RC and So KF:
Research advances on the usage of traditional Chinese medicine for
neuroprotection in glaucoma. J Integr Med. 11:233–240. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang HY, Yi XN, Liu YH, Lao ML and Zhang
XF: The protective effect of puerarin on Abeta(25–35)-induced PC12
cell injury. Zhong Yao Cai. 33:763–767. 2010.(In Chinese).
PubMed/NCBI
|
|
15
|
Zhang W, Liu CQ, Wang PW, Sun SY, Su WJ,
Zhang HJ, Li XJ and Yang SY: Puerarin improves insulin resistance
and modulates adipokine expression in rats fed a high-fat diet. Eur
J Pharmacol. 649:398–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L and Zhao Y: Effect of decoction
method on pharmacokinetics of puerarin in dogs. Zhong Yao Cai.
33:1442–1444. 2010.(In Chinese). PubMed/NCBI
|
|
17
|
Li J, Wang G, Liu J, Zhou L, Dong M, Wang
R, Li X, Li X, Lin C and Niu Y: Puerarin attenuates
amyloid-beta-induced cognitive impairment through suppression of
apoptosis in rat hippocampus in vivo. Eur J Pharmacol. 649:195–201.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu CM, Ma JQ and Sun YZ: Puerarin
protects the rat liver against oxidative stress-mediated DNA damage
and apoptosis induced by lead. Exp Toxicol Pathol. 64:575–582.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng ZQ, Wang YY, Guo ZR, Chu FM and Sun
PY: The synthesis of puerarin derivatives and their protective
effect on the myocardial ischemia and reperfusion injury. J Asian
Nat Prod Res. 12:843–850. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiao S, Wang J and Xiao N: MicroRNAs as
noninvasive biomarkers in bladder cancer detection: A diagnostic
meta-analysis based on qRT-PCR data. Int J Biol Markers.
31:e276–e285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wai-Hoe L, Wing-Seng L, Ismail Z and
Lay-Harn G: SDS-PAGE-based quantitative assay for screening of
kidney stone disease. Biol Proced Online. 11:145–160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Steinhart MR, Cone FE, Nguyen C, Nguyen
TD, Pease ME, Puk O, Graw J, Oglesby EN and Quigley HA: Mice with
an induced mutation in collagen 8A2 develop larger eyes and are
resistant to retinal ganglion cell damage in an experimental
glaucoma model. Mol Vis. 18:1093–1106. 2012.PubMed/NCBI
|
|
24
|
Tanaka T, Imamura T, Yoneda M, Irie A, Ogi
H, Nagata M, Yoshida R, Fukuma D, Kawahara K, Shinohara M and
Nakayama H: Enhancement of active MMP release and invasive activity
of lymph node metastatic tongue cancer cells by elevated signaling
via the TNF-α-TNFR1-NF-kB pathway and a possible involvement of
angiopoietin-like 4 in lung metastasis. Int J Oncol. 49:1377–1384.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ao X, Sellati TJ and Stenken JA: Enhanced
microdialysis relative recovery of inflammatory cytokines using
antibody-coated microspheres analyzed by flow cytometry. Anal Chem.
76:3777–3784. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Awodele O, Oreagba IA, Olayemi SO, Oladipo
I, Iruegbukpe CO, Balogun BG, Balogun MM and Adedokun AO:
Evaluation and comparison of the indices of systemic oxidative
stress among Black-africans with Age-related cataracts or primary
glaucoma. Middle East Afr J Ophthalmol. 22:489–494. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeon S, Lee NY and Park CK: Neovascular
glaucoma following stereotactic radiosurgery for an optic nerve
glioma: A case report. Korean J Ophthalmol. 24:252–255. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Widder RA, Lemmen KD and Dietlein TS:
Neovascular glaucoma. Klin Monbl Augenheilkd. 227:R15–R27. 2010.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Toyama S, Tsuji H, Mizoguchi N, Nomiya T,
Kamada T, Tokumaru S, Mizota A, Ohnishi Y and Tsujii H: Working
Group for Ophthalmologic Tumors: Long-term results of carbon ion
radiation therapy for locally advanced or unfavorably located
choroidal melanoma: Usefulness of CT-based 2-port orthogonal
therapy for reducing the incidence of neovascular glaucoma. Int J
Radiat Oncol Biol Phys. 86:270–276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wittström E, Holmberg H, Hvarfner C and
Andréasson S: Clinical and electrophysiologic outcome in patients
with neovascular glaucoma treated with and without bevacizumab. Eur
J Ophthalmol. 22:563–574. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Laplace O: Surgical session: Neovascular
glaucoma and anti-vascular endothelial growth factor treatment. J
Fr Ophtalmol. 32:230–235. 2009.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Simha A, Braganza A, Abraham L, Samuel P
and Lindsley K: Anti-vascular endothelial growth factor for
neovascular glaucoma. Cochrane Database Syst Rev: CD007920. 2013.
View Article : Google Scholar
|
|
33
|
Reilly CM, Morris R and Dubielzig RR:
Canine goniodysgenesis-related glaucoma: A morphologic review of
100 cases looking at inflammation and pigment dispersion. Vet
Ophthalmol. 8:253–258. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang L, Wong T, Ohbayashi M, Bunce C,
Barton K, Ono SJ and Khaw PT: Increased mast cell numbers in the
conjunctiva of glaucoma patients: A possible indicator of
preoperative glaucoma surgery inflammation. Eye (Lond).
23:1859–1865. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Furtado JM, Paula JS, Soares EG, Dhegaide
NH, Rocha EM, Donadi E and Mde Rodrigues L: Conjunctival
inflammation in patients under topical glaucoma treatment with
indication to surgery. Acta Cir Bras. 27:732–735. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vohra R, Tsai JC and Kolko M: The role of
inflammation in the pathogenesis of glaucoma. Surv Ophthalmol.
58:311–320. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ha Y, Liu H, Xu Z, Yokota H, Narayanan SP,
Lemtalsi T, Smith SB, Caldwell RW, Caldwell RB and Zhang W:
Endoplasmic reticulum stress-regulated CXCR3 pathway mediates
inflammation and neuronal injury in acute glaucoma. Cell Death Dis.
6:e19002015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schlötzer-Schrehardt U: Oxidative stress
and pseudoexfoliation glaucoma. Klin Monbl Augenheilkd.
227:108–113. 2010.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mangan BG, Al-Yahya K, Chen CT, Gionfriddo
JR, Powell CC, Dubielzig RR, Ehrhart EJ and Madl JE: Retinal
pigment epithelial damage, breakdown of the blood-retinal barrier,
and retinal inflammation in dogs with primary glaucoma. Vet
Ophthalmol. 10 Suppl 1:S117–S124. 2007. View Article : Google Scholar
|
|
40
|
Tezel G, Yang X, Luo C, Kain AD, Powell
DW, Kuehn MH and Kaplan HJ: Oxidative stress and the regulation of
complement activation in human glaucoma. Invest Ophthalmol Vis Sci.
51:5071–5082. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chi W, Chen H, Li F, Zhu Y, Yin W and Zhuo
Y: HMGB1 promotes the activation of NLRP3 and caspase-8
inflammasomes via NF-kB pathway in acute glaucoma. J
Neuroinflammation. 12:1372015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Itakura T, Peters DM and Fini ME:
Glaucomatous MYOC mutations activate the IL-1/NF-kB inflammatory
stress response and the glaucoma marker SELE in trabecular meshwork
cells. Mol Vis. 21:1071–1084. 2015.PubMed/NCBI
|
